NYSE International 100

NYSE International 100 handeln
10.756,79 PKT +273,65 PKT +2,61 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Analysen zu NYSE International 100-Werten

Datum Rating Analyst
23.07.19 Santander Conviction Buy List Goldman Sachs Group Inc.
23.07.19 UBS Neutral Goldman Sachs Group Inc.
23.07.19 Santander Neutral UBS AG
23.07.19 Philips buy UBS AG
23.07.19 Novartis Neutral UBS AG
23.07.19 GSK Neutral UBS AG
23.07.19 Unilever Outperform Credit Suisse Group
23.07.19 Telefonica buy Deutsche Bank AG
23.07.19 National Grid buy Deutsche Bank AG
23.07.19 UBS overweight JP Morgan Chase & Co.
23.07.19 Philips Neutral JP Morgan Chase & Co.
23.07.19 UBS buy Goldman Sachs Group Inc.
23.07.19 UBS Neutral Goldman Sachs Group Inc.
23.07.19 Deutsche Bank Neutral Goldman Sachs Group Inc.
22.07.19 GSK buy Goldman Sachs Group Inc.
22.07.19 Allianz Neutral Goldman Sachs Group Inc.
22.07.19 Orange buy Deutsche Bank AG
22.07.19 Nokia Outperform Credit Suisse Group
22.07.19 Novartis Conviction Buy List Goldman Sachs Group Inc.
22.07.19 Philips Conviction Buy List Goldman Sachs Group Inc.
22.07.19 SAP Neutral UBS AG
22.07.19 Novartis Hold HSBC
22.07.19 SAP buy Jefferies & Company Inc.
19.07.19 Santander Conviction Buy Goldman Sachs Group Inc.
19.07.19 BBVA Neutral Goldman Sachs Group Inc.
19.07.19 Siemens overweight JP Morgan Chase & Co.
19.07.19 Lloyds Banking Group Neutral Goldman Sachs Group Inc.
19.07.19 Barclays buy UBS AG
19.07.19 SAP buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
19.07.19 Deutsche Bank Underperform Credit Suisse Group
19.07.19 SAP Outperform Credit Suisse Group
19.07.19 Novartis Neutral Credit Suisse Group
19.07.19 Diageo Outperform Credit Suisse Group
19.07.19 Diageo Underperform Bernstein Research
19.07.19 SAP Conviction Buy List Goldman Sachs Group Inc.
19.07.19 Vodafone Group buy HSBC
19.07.19 SAP buy HSBC
19.07.19 Novartis Hold Deutsche Bank AG
19.07.19 SAP overweight Barclays Capital
19.07.19 Novartis Underweight Barclays Capital